??Celebrating 120 Days of my Journey as a full-time social entrepreneur!??
Participating in a training session for staff of private health facilities

??Celebrating 120 Days of my Journey as a full-time social entrepreneur!??

My dearest readers,

I had planned to mark my 100-day milestone as a dedicated full-time social entrepreneur with a profound LinkedIn post. Alas, time has hastened its stride, and I find myself already at the 120-day mark of my enthralling journey. Though 120 days may seem but a fleeting moment in the life of Enovpharm, our esteemed organization, the unwavering dedication of my extraordinary team has already begun to yield delightful and captivating results. Today, I am overjoyed to share with you an update presented in the style reminiscent of the beloved series, Bridgerton. So, do find respite in a comfortable nook, unwind, and immerse yourself in the following words!

In the maiden month of our sojourn, I undertook the mantle of organizing a series of meetings and workshops that united diverse actors within the realm of public health. Esteemed figures from the Ministry of Health, officials from the Enlarged Program of Immunization, and the illustrious heads of health districts gathered alongside representatives from private sector entities, such as esteemed associations of pharmacies and clinics. Our collective purpose was to convene and engage in discourse surrounding VACCIPHA—an audacious initiative endeavoring to engross private pharmacies and clinics in the realm of routine immunization, fortified by the power of a digital solution. Through tireless consultations, our ardent endeavors bore fruit, resulting in the attainment of consensus and the finalization of a charter. This esteemed document shall act as our guiding star as we venture forth, commencing in the vibrant city of Abidjan before graciously extending its reach nationwide. My heart swells with pride at this accomplishment, for I played a vital role in igniting this intervention and facilitating consensus among an illustrious list of stakeholders, hailing from both the private and public domains. Ultimately, the Ivorian populace shall reap the bountiful rewards of our collective dedication. Since that fateful moment, bolstered by the unwavering support of MTaPS and EPI, alongside the sagacious leadership of our esteemed health districts, we have diligently trained over 100 staff members hailing from private health facilities. They shall rise to the occasion, gallantly spearheading the implementation of this innovative intervention at the grassroots level.

Moreover, destiny bestowed upon me an extraordinary opportunity—a chance to secure a subcontract with Salient Advisory. This noble endeavor has granted me the privilege of collaborating with a select group of four Senior Technical Advisors (STAs), who have taken up arms in an initiative blessed by the illustrious Bill and Melinda Gates Foundation. The noble aim of this endeavor is to fortify pharmaceutical regulatory agencies across a constellation of African nations, ushering forth enhanced access to life-saving health products through the sacred realm of online pharmacies. This auspicious path has not only enriched Enovpharm's storied tapestry but has also granted me the opportunity to glean wisdom from my esteemed fellow STAs, their collective knowledge illuminating my path. Furthermore, I am indebted to the resolute support provided by the indomitable Salient Team, led by the esteemed Remi Adeseun. This extraordinary opportunity has not only bolstered my track record but has also expanded the horizons of my expertise within this noble realm.

In addition to the illustrious achievements previously mentioned, Enovpharm embarks upon an exhilarating collaboration with the esteemed Nutrition Program in C?te d'Ivoire. Our shared goal is to establish an exalted privatized supply chain for nutrition products, ensuring their divine availability at the final frontier. In this sacred alliance, the esteemed Nutrition Program has expressed their ardent interest in entrusting Enovpharm with the noble task of safeguarding, transporting, and distributing these precious products to private pharmacies and clinics, thereby multiplying the points of contact with our cherished populace. Furthermore, through this divine collaboration, Enovpharm endeavors to streamline the evaluation of nutrition status through the implementation of a sacred digital solution. This audacious endeavor, brimming with promise, seeks strong partnerships and the benevolent embrace of funding support. Therefore, we fervently engage with the esteemed program, inviting enlightened souls, collaborators, and benefactors who resonate with our sacred mission to step forward. Should this divine initiative stir your heart or if you possess insights and resources to contribute, I implore you to reach out. Collaboration is equally welcomed for our esteemed VACCIPHA initiative. We extend a most heartfelt invitation to esteemed organizations, whether bequeathed by the public or private realm, tech visionaries, benevolent funders, and all souls possessing a vested interest, to unite with us as one. Together, let us forge an indomitable force upon these impactful projects. Your contributions and support are cherished treasures, invaluable to our collective endeavor, and we eagerly anticipate the harmonious symphony of our collaboration.

Amidst the unyielding demands that adorn my bustling schedule, I have remained steadfast in my role as a TB Advocate. For those unaware, I proudly hold the mantle of chairmanship within the esteemed Global TB Community Advisory Board. Additionally, I am honored to grace the ranks of the Community Advisory Group of Unite4TB, and my heart dances with delight as a cherished member of the WHO expert group. This illustrious assembly toils diligently, crafting a sacred framework for the future introduction of new TB vaccines. In these esteemed capacities, I have actively participated in a constellation of meetings and enlightening webinars. In the forthcoming chapters of our journey, I shall share with you peer-reviewed publications, which encapsulate the resounding voices of our cherished community. These sacred texts shall unveil diverse aspects of TB access, treatment, and prevention, entwined with the vibrant tapestry of community perspectives.

In the spirit of transparency and candor, I must now turn my gaze to areas within my entrepreneurial odyssey that yearn for improvement. Foremost, our public communication efforts, dedicated to shedding light upon Enovpharm and its awe-inspiring achievements, must be elevated to new heights. Amidst the tumultuous tempest of competing priorities, I have regrettably fallen short in consistently sharing captivating visuals and timely updates that illuminate the extraordinary work unfolding before our very eyes. This deficiency has hindered the efficacy of our esteemed communications team, as my feedback to finalize our website and professional pages remains outstanding. I beseech you, dear readers, to join us on this remarkable journey, despite the occasional typographical imperfections that may dot our path. I pledge to promptly address these concerns and invite you to follow our sacred page, that you may remain steadfastly informed.

Secondly, and with utmost importance, I humbly admit that during these formative 120 days, my social connections have not been as ardent as my heart yearns for. Be it through the dulcet tones of melodic phone calls, the wistful musings of thoughtful text messages, or the ephemeral whispers of spirited WhatsApp conversations, I have inadvertently allowed these cherished bonds to wane. Moving forward, I shall embark upon a resolute path, devoting myself to the nurturing of these cherished relationships, ensuring their rightful place of prominence throughout the remaining chapters of this year.

Lastly, it is with utmost reverence that I acknowledge the absence of repose since my transition from the realm of a full-time employee to the audacious realm of a resolute entrepreneur. Bereft of a moment's respite or the opportunity for profound contemplation, I have been caught in an unceasing tempest. Yet, within this moment of self-reflection, I am struck by the undeniable truth that the key to enduring success lies in cherishing moments of serenity, allowing for introspection and strategic contemplation. Addressing this critical aspect is of paramount importance, and I pledge myself to the pursuit of a healthier equilibrium as we journey forth.

As I gaze upon the exquisite tapestry woven by the past 120 days, my heart swells with boundless gratitude for the remarkable achievements made possible by the unwavering commitment of my extraordinary team. The path that unfurls before us may be adorned with formidable challenges, yet armed with the wisdom gleaned from lessons learned and fortified by the spirit of improvement, I hold anunwavering belief in Enovpharm's ability to flourish and enact a profound impact upon the health and well-being of our cherished populace. I extend my deepest gratitude to each and every one of you, dear readers, for your unwavering support upon this remarkable adventure. Together, let us forge a harmonious symphony of positive change, shaping a future radiant with brilliance.

With profound gratitude, Yvan Agbassi (written by Lady Whistledown)

Edwin Mulwa, FAPH

Leading the co-creation and implementation of digital solutions to strengthen equitable public health systems

1 年

Well done! Keep shining!

Remi ADESEUN

Founder at Aderemi Adeseun Advisory Inc.

1 年

Yvan Jean Patrick Agbassi It has been an absolute pleasure for all of us at Salient Advisory and Pharmacy Regulators from 13 African Countries to have your expertise and extraordinary passion for transformation of African Health Systems through innovation. Health Tech Innovators from around the continent also appreciate you, for facilitating meaningful engagement with the leadership of the Autorité Ivoirienne de Régulation Pharmaceutique (AIRP) and the Ministry of Health in Cote d'Ivoire during the recent @African CEO Forum in Abidjan (June 6th). We look forward to continuing to collaborate with you and Enovpharm. Assane Coulibaly EDI KOUADJANE CHARLES Chekkit Meditect Appy DrugStoc Sobrus VaxiGlobal VIEBEG Remedia Health

This is so great to hear Yvan Jean Patrick Agbassi - fun to see the progress and excited to see you joining up with Salient Advisory as well.

Félicitations chief, beaucoup de succès

Lise Carmen BATIANA

Program Coordinator & Responsable de Centre de Formation chez SOGEA SATOM (VINCI Construction)

1 年

Well done Yvan Jean Patrick Agbassi ! Proud of you

要查看或添加评论,请登录

社区洞察

其他会员也浏览了